Search
for
Sort by
Research 241–270 of 336
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Hair and nail adverse events during treatment with targeted therapies for metastatic melanoma
- Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs
- RASopathic alopecia: Hair changes associated with vemurafenib therapy
- The spectrum of cutaneous adverse events during encorafenib and binimetinib treatment in B‐rapidly accelerated fibrosarcoma‐mutated advanced melanoma
- Management of Dermatologic Toxicities
- Vemurafenib-induced pityriasis amiantacea: a case report
- Hair(y) Matters in Melanoma Biology
- At the Root: Cutaneous Langerhans Cell Histiocytosis
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- The Influence of Flightless I: Regeneration versus Wound Healing
- Alopecia due to chemotherapeutics, hedgehog inhibitors, targeted antibody therapies and immune checkpoint inhibitors
- Dyad of infantile cutaneous and thymic Langerhans cell histiocytosis: Is it rare?
- Inflammatory and non-melanocytic tumoral pathology of the nail
- Tombo em João Pessoa dá força a Memorial da Arquitetura Paraibana
- RASopathic Skin Eruptions during Vemurafenib Therapy
- Targeted therapy in melanoma
- Genetics of thyroid lesions updated
- Progress in Dermatology and Venereology in 2023 as reflected in the Journal of the European Academy of Dermatology and Venereology
- Management of Toxicities of Targeted Therapies
- Sorafenib combined with hepatectomy in patients with intermediate-stage and advanced hepatocellular carcinoma
- America - A Diversity of Life Styles.
- Kinase Inhibition with BAY 43–9006 in Renal Cell Carcinoma
- Can you diagnose hair loss (Non-scarring alopecia)
- Post-oncologic skin health: cutaneous recovery and rehabilitation after cancer treatments
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- Treatment of Hair Loss
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Drug-induced acne